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Background: The incidence and risk factors of suicide reattempts within 1 year after psychiatric 
hospital discharge in mood disorder patients remain uninvestigated in Thailand.
Objective: To determine incidence and risk factors of suicide reattempts within 1 year after 
psychiatric hospital discharge in mood disorder patients.
Methods: A retrospective cohort study was conducted by reviewing medical charts at   Suanprung 
Psychiatric Hospital, Chiang Mai, Thailand. Mood disorder patients, diagnosed with the 
  International Statistical Classification of Diseases and Related Health Problems 10th Revision 
codes F31.x, F32.x, and F33.x, who were admitted owing to suicide attempts between October 
2006 and May 2009 were eligible. The influence of sociodemographic and clinical risk factors 
on suicide reattempts was investigated using Cox’s proportional-hazards regression analysis.
Results: Of 235 eligible mood disorder patients, 36 (15.3%) reattempted suicide (median 
109.5 days, range 1–322), seven (3.0%) completed suicide (median 90 days, range 5–185), and 
192 (84.2%) neither reattempted nor completed suicide during follow-up. Of all nonfatal suicide 
reattempts, 14 patients (38.9%) did so within 90 days.  Among suicide completers, one (14.3%) 
did so 5 days after discharge, and four (57.1%) did so within 90 days. The following three risk 
factors explained 73.3% of the probability of suicide reattempts: over two previous suicide 
attempts before the index admission (adjusted hazard ratio [HR] 2.48; 95% confidence interval 
[CI] 1.07–5.76), being concomitantly prescribed typical and atypical antipsychotics (adjusted 
HR 4.79; 95% CI 1.39–16.52) and antidepressants, and taking a selective serotonin reuptake 
inhibitor alone (adjusted HR 5.08; 95% CI 1.14–22.75) or concomitantly with norepinephrine 
and/or serotonin reuptake inhibitors (adjusted HR 6.18; 95% CI 1.13–33.65).
Conclusion: Approximately 40% of suicide reattempts in mood disorder patients occurred 
within 90 days after psychiatric hospital discharge. For mood disorders and when there have 
been over two previous suicide attempts, prescribed antipsychotics or antidepressants may help 
predict suicide reattempts.
Keywords: bipolar disorders, major depressive disorders, suicide attempts, suicide 
completions
Introduction
Mood disorders are disturbances in a person’s mood categorized into major depres-
sive disorder (MDD) and bipolar disorder (BD). MDD and BD appear to be the most 
important risk factors for lifetime suicide in any psychiatric disorder.1 It has been 
estimated that at the time of suicide, 87.3%–98% of psychiatric disorders are from 
mood disorders and substance abuse.2
Among mood disorder patients who attempt suicide, reattempt is more common 
than the first act.3 The prevalence of reattempted suicide within 1 year after the index 
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suicide attempt is 16%–40% nonfatal and 2% fatal.4,5 Risk 
of reattempted suicide following a psychiatric admission is 
highest during the first months after the attempt and declines 
over time.6
Several risk factors for suicide attempts reported in MDD 
and BD patients include male sex,7,8 age,5,7 living alone on the 
day of the index attempt,9 smoking,10 alcohol abuse,9 previous 
number of suicide attempts,9–12 method of suicide attempt,9 
severity of refractory or recurrent depressions,10,12 somatic 
illness,9 suicide intent and treatment of mental illness,7,9,11 
hospitalization in a psychiatric department, and the use of 
psychopharmacological drugs during the follow-up period. 
Other risk factors are impulsivity, stressful life events, hope-
lessness, being unemployed,13 comorbidity with anxiety and 
agitation, and reporting suicidal plans or hallucinations at the 
time of the index episode.14
The current study was undertaken at a setting located in 
the upper northern part of Thailand where the suicide attempt 
rate of 34.1 per 100,000 population is remarkably high. 
The suicide completion rate was the highest in the nation 
at 12.4 per 100,000 population compared with 5.97 per 
100,000 population countrywide in 2009. Mood disorders 
rank among the top five high-burden diseases in this setting 
every year. Among those diagnosed with mood disorders, 
25% are hospitalized due to suicide attempts.15 Suicide reat-
tempts are prevalent in this vulnerable population; however, 
the incidence and risk factors of suicide reattempts in mood 
disorder patients have not yet been investigated in this area. 
Furthermore, consensus on suicide attempt risk factors is still 
unclear because of their complexity, and the generalizability 
of previous research may be limited due to discrepancies 
of cultural context, study populations, design, and data 
  analysis. Thus, there is a need for studies of incidence and 
risk factors for suicide reattempts in mood disorder patients 
in Thailand. The present study aimed to determine incidence 
and explored risk factors of suicide reattempts occurring 
within 1 year after psychiatric hospital discharge in mood 
disorder patients.
Methods
Study population and setting
Suanprung Psychiatric Hospital is the largest tertiary 
  psychiatric hospital (700 beds) in the upper northern region of 
Thailand. It is located in Chiang Mai and has been   providing 
medical care since 1938. In 2009, the hospital provided 
services to 6721 inpatients and 61,561 outpatients. Mood 
disorder inpatient and outpatient visits for 2007, 2008, and 
2009 were 9069, 10,739, and 11,482, respectively.16
Eligible patients were all mood disorder patients diag-
nosed by psychiatrists and coded by the International Statisti-
cal Classification of Diseases and Related Health Problems 
10th Revision (ICD-10). Inclusion criteria were patients 
diagnosed with ICD-10 codes F31.x, F32.x, and F33.x and 
admitted to Suanprung Psychiatric Hospital owing to suicide 
attempts between October 2006 and May 2009.
Outcome definitions and measures
People who reattempted suicide were those mood disorder 
patients who reattempted nonfatal suicide within 1 year after 
an admission to Suanprung Psychiatric Hospital owing to 
attempted suicide. Eligible patients’ medical charts were 
examined for the main outcome of the study, which was 
time to suicide reattempts. Time to suicide reattempts was 
defined as the number of days within 1 year from the date 
of hospital discharge to the suicide reattempt date. Patients 
who did not reattempt suicide during the 1 year of follow-up 
or with whom contact was lost before the 1-year follow-up 
were considered a censor group. Their time at risk from 
the index date to censoring time was collected. Further, the 
national death registration was searched and death date and 
cause of death were retrieved. A cause of death was further 
confirmed by telephone calls to the patient’s spouse or next of 
kin. To determine risk factors for suicide reattempts, suicide 
completers were excluded from the analysis, because this 
population did not overlap.
Data collection
The study was designed as a retrospective cohort study. 
Patients’ medical files were reviewed from the day of admis-
sion and followed for 1 year after hospital discharge. The 
admission time was set as an index date. Patient informa-
tion recorded in hospital files was routinely assessed and 
documented with a standardized procedure by psychiatrists, 
trained psychiatric nurses, and pharmacists who interviewed 
patients and/or their relatives. Five trained nurses working at 
the study site extracted data and filled in a case record form. 
To assure validity of the data, two meetings were held by 
the research team to discuss and clarify each variable in the 
files before data collection. Undocumented variables were 
considered to be missing.
Sociodemographic factors and clinical factors were the 
main indicators collected in the study. All factors were selected 
and divided into categories based on a literature review 
and the opinion of psychiatrists on the research team. 
The   sociodemographic factors included were sex, age, body 
mass index, marital status, educational level, occupation, 
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  religion, living status (alone or with others), number of chil-
dren, and summation of number of stressful life events right 
before or at the index episode. Social support was divided 
into good or excellent, moderate, and little or very little.
Clinical factors included ICD-10 diagnoses of BD (coded 
F31.x) and MDD (coded F32.x and F33.x). Duration of 
treatment began from the time of the first diagnosis to the 
index date, and age at onset was the age at the first visit. 
Previous admission referred only to admission to   Suanprung 
  Psychiatric Hospital before the index date. Previous   suicide 
attempt and previous suicidal ideation were assessed and 
counted from the first hospital visit to the index date. 
  Psychotic symptoms at an index episode included hallucina-
tion and hearing voices. Psychotic comorbidity was extracted 
from the ICD-10 code and was recorded and grouped into 
alcohol/substance dependence, which was commonly 
found, and others. Somatic illness was any chronic disease. 
  Smoking, alcohol use, and any substance abuse were behav-
iors at the index date. Medication adherence was assessed 
by attending pharmacists asking patients or their relatives 
about consistency in taking medication during the 2 weeks 
before the index date. It was summarized as “highly adhere,” 
meaning the patient always took medication or rarely missed 
a dose, “intermittently adhere,” meaning the patient took 
medication off and on, and “poorly adhere,” meaning at 
least seven consecutive days when the patient did not take 
medication. Other clinical characteristics included family 
history of mental disorders and family history for attempted 
or completed suicide.
An additional variable collected was the number and 
type of method(s) used for suicide attempt at the index date. 
The method was considered a violent method if it was (1) a 
method other than drug overdose or a single wrist cut or (2) a 
combination of different methods.17 Treatments received 
during the admission included pharmacotherapy, electrocon-
vulsive therapy, and psychotherapy. Pharmacotherapy was 
prescribed medication, which we categorized according to 
the mechanism of action and evidence of relation to suicide. 
Mood stabilizers were categorized either as lithium or others, 
such as carbamazepine and valproate. Antidepressants were 
grouped as norepinephine and/or serotonin reuptake inhibi-
tors, such as amitriptyline and venlafaxine, or as selective 
serotonin reuptake inhibitors (SSRIs), such as fluoxitine 
and fluvoxamine. Antipsychotics were divided into typical, 
such as zuclopentizol and haloperidol, and atypical, such as 
clozapine and risperidone. Anxiolytics consisted of benzodi-
azepine and others, such as chlodiazepoxide. Psychotherapy 
included individual and group counseling, family counseling, 
and rehabilitation. Additionally, data on length of stays and 
readmission within 28 days were also collected.
Statistical analyses
Because time to suicide reattempts was an outcome of the 
study, Cox’s proportional-hazards regression was used for 
the analysis. Owing to the nature of the fitting exploration 
model, we determined the best parsimonious model by 
performing two steps of analysis. First, variables predicting 
suicide reattempts were explored using univariable Cox’s 
proportional-hazards regression. Those with a P-value less 
than 0.20 were selected for the last step, in which forward 
elimination multivariable Cox’s proportional-hazards 
regression was selected. The global goodness-of-fit test by 
Schoenfeld was used for testing the proportional-hazards 
assumption.18 In order to assess the model prediction, we 
used the area under receiver operating characteristic curve 
method. The statistical significance level was set at 0.05. 
Two institutional review boards, the Faculty of Medicine at 
Chiang Mai University and Suanprung Psychiatric Hospital, 
approved the protocol of the study.
Results
A total of 235 patients’ medical folders were reviewed and 
included in the analysis (Figure 1). Of those, 36 (15.32%) 
reattempted suicide (median 109.5 days, range 1–322), seven 
(2.98%) completed suicide (median 90 days, range 5–185), 
and 192 (84.21%) neither reattempted nor completed sui-
cide during follow-up. Of all nonfatal suicide reattempts, 
14 patients (38.9%) did so within 90 days. Among suicide 
completers, one (14.3%) did so 5 days after discharge, and 
four (57.1%) did so within 90 days. Total time of follow-up 
in each group is presented in Table 1.
Univariable  analysis  found  that  stressful  life 
events, psychotic symptoms, and previous suicide attempts 
were significantly associated with suicide reattempts 
(Tables 2 and 3).
Three risk factors that explained 73.3% of the probability 
of suicide reattempt were attempting suicide more than twice 
before the index admission (adjusted hazard ratio [HR] 2.48; 
95% confidence interval [CI] 1.07–5.76], concomitantly 
prescribed typical and atypical antipsychotics (adjusted HR 
4.79; 95% CI 1.39–16.52), or taking SSRI alone (adjusted 
HR 5.08; 95% CI 1.14–22.75) or with norepinephrine and/or 
serotonin reuptake inhibitors (adjusted HR 6.18; 95% CI 
1.13–33.65). In addition, readmission within 28 days was 
significantly higher in the suicide reattempt group (18.8% vs 
5.1%, P = 0.008) (data not shown) (Table 4).
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Discussion
To the best of our knowledge, the present study is the first 
to determine incidence and explore risk factors of suicide 
reattempts within 1 year after psychiatric hospital discharge 
in mood disorder patients. In this study, the incidence of 
suicide reattempts and suicide completions within 1 year 
of follow-up after attempted suicide was 15.3% and 3.0%, 
respectively. This finding is consistent with previous stud-
ies that reported suicide reattempts at 13.6%–16%6,13 and 
suicide completions at 1%–3%.19 Although the median time 
of suicide reattempts in the present study was longer than 
in a previous study (109.5 days vs 73.5 days),13 almost 40% 
of nonfatal suicide reattempts of the patients in this study 
occurred within 90 days. The reattempt rate is more likely to 
be clustered in time because the incidence declines through-
out the year of follow-up.6 Therefore, intensive surveillance, 
timely assessment, and effective interventions should be 
emphasized during the first few months and continue for   
1 year after hospital discharge.
Using the best fit and simple model, we found three 
risk factors that indicated suicide reattempts: more than 
two previous suicide attempts before the index   admission, 
concomitantly being prescribed typical and atypical 
  antipsychotics, and taking an SSRI alone or concomitantly 
with norepinephrine and/or serotonin reuptake inhibitors. 
  Previous suicide attempts before the index date is a risk 
Mood disorder patients admitted
during 2007–2009 (n = 2,102)  
Exclusion:
mood disorder patients admitted
due to other reasons (n = 1,867) 
Mood disorder patients admitted due to  
suicide attempt (n = 235)
Exclusion:
suicide completions (n = 7)
Suicide reattempts (n = 36) No suicide reattempts (n = 192)
Figure 1 Data flow.
Table 1 Incidence of suicide reattempts and suicide completions within 1 year after hospital discharge in mood disorder patients 
(n = 235)
Parameters Suicide reattempts (n = 36) Suicide completions (n = 7) No reattempts (n = 192)
Cumulative incidence (%) 15.32 2.98
Incidence rate per 1000 population 8.45 9.65
Total person-days at risk 4261 725 35,616
Median days (min–max) 109.5 (1–322) 90 (5–185) 168.5 (1–365)
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factor   associated with suicide reattempts found in several 
studies.9–12 In the present study, 74.4% percent of patients 
had at least one prior suicide attempt before the index date. 
The hazard ratios increased with an increasing number of 
previous suicide attempt(s), demonstrating that patients 
with more prior attempts tended to be more severe, be more 
impulsive, and take more risks.20
Regarding the use of medication, psychopharmacological 
use prior to and during the follow-up period is a predictor 
for suicide attempt.6 Suicide reattempts increased in mood 
disorder patients prescribed with antipsychotics or antide-
pressants. This is in accordance with a meta-analysis study 
reporting that antidepressants were not beneficial for suicidal 
patients.21 However, in some previous studies,22 long-term 
treatment with antidepressants was found to reduce suicides 
significantly when combined with lithium and antipsychotics. 
Antipsychotic users were more likely to reattempt suicide 
in this study. The ability of most antipsychotics to limit the 
risk of suicidal behavior remains untested in the literature.23 
The positive relationship results of antidepressant and 
antipsychotic use in this study may be due to confounding 
indications. Patients prescribed with more types of medica-
tion were those who were more severe and prone to a higher   
number of suicide reattempts.
Table 2 Sociodemographic factors of mood disorder patients and unadjusted hazard ratio (HR) (95% confidence interval [CI]) of 
suicide reattempts by univariable Cox’s proportional-hazards regression analysis (n = 228)
Sociodemographic risk factorsa Suicide reattempts Unadjusted HR 
(95% CI)
P-value
Yes (n = 36) No (n = 192)
Sex 0.882
  Male 16 (17.8) 74 (82.2) 1.0
  Female 20 (14.5) 118 (85.5) 0.95 (0.49–1.84)
Age (years) 36.8 (±13.9) 37.7 (±14.4) 0.99 (0.97–1.01) 0.388
Body mass index (kg/m2) 21.8 (±3.3) 22.2 (±4.1) 0.97 (0.89–1.06) 0.553
Education
  No or primary school 17 (17.0) 83 (83.0) 1.0
  Junior to high school 14 (20.0) 56 (80.0) 1.24 (0.61–2.52) 0.550
  Diploma or higher 5 (11.1) 40 (88.9) 0.62 (0.23–1.68) 0.346
Marital status
  Single 12 (15.4) 66 (84.6) 1.0
  Married 16 (14.3) 96 (85.7) 0.79 (0.37–1.67) 0.536
  Widow/divorce or others 8 (22.2) 28 (77.8) 1.34 (0.55–3.29) 0.516
Occupation
  Officer 18 (19.1) 76 (80.9) 1.0
  Labor 8 (16.3) 41 (83.7) 0.95 (0.41–2.20) 0.913
  Housewife/student 2 (7.1) 26 (92.9) 0.31 (0.07–1.34) 0.116
  Unemployed 8 (14.8) 46 (85.2) 0.86 (0.37–1.97) 0.713
Religion
  Buddhism 35 (16.6) 176 (83.4) 1.0
  Others 1 (12.5) 7 (87.5) 0.74 (0.10–5.41) 0.769
Number of children
  None 7 (15.6) 38 (84.4) 1.0
  One to two 4 (7.4) 50 (92.6) 0.54 (0.16–1.86) 0.330
  More than two 4 (21.0) 15 (79.0) 1.32 (0.39–4.52) 0.656
Living status
  Alone 2 (11.8) 15 (88.2) 1.0
  With family 31 (17.7) 144 (82.3) 1.23 (0.30–5.17) 0.773
  With others 1 (5.6) 17 (94.4) 0.48 (0.04–5.29) 0.549
Social support
  good or excellent 19 (17.3) 91 (82.7) 1.0
  Moderate 2 (6.7) 28 (93.3) 0.43 (0.10–1.86) 0.262
  Very little or little 12 (20.0) 48 (80.0) 1.18 (0.57–2.43) 0.654
Stressful life events
  None 10 (33.3) 20 (66.7) 1.00
  One event 14 (13.6) 89 (86.4) 0.38 (0.17–0.87) 0.021
  Two events 5 (8.5) 54 (91.5) 0.23 (0.08–0.68) 0.008
  More than two events 7 (19.4) 29 (80.6) 0.53 (0.20–1.39) 0.196
Note: aNumbers are n (%) or mean (± standard deviation).
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Table 3 Clinical factors of mood disorder patients and unadjusted hazard ratio (HR) (95% confidence interval [CI]) of suicide reattempts 
by univariable Cox’s proportional-hazards regression analysis (n = 228)
Clinical factorsa Suicide reattempts Unadjusted HR 
(95% CI)
P-value
Yes (n = 36) No (n = 192)
ICD-10
  Bipolar 9 (17.0)  44 (83.0) 1.0
  Major depressive disorder 27 (15.4) 148 (84.6) 1.00 (0.47–2.12) 0.993
Somatic illness
  No 26 (16.2) 134 (83.8) 1.0
  One disease 7 (13.2) 46 (86.8) 0.90 (0.39–2.08) 0.812
  Two or more diseases 3 (20.0) 12 (80.0) 1.39 (0.42–4.49) 0.592
Psychotic comorbidity
  No 28 (16.3) 144 (83.7) 1.0
  Yes 6 (18.2) 27 (81.8) 1.24 (0.51–3.00) 0.631
Age under 18 years at onset
  No 2 (10.5) 17 (89.5) 1.0
  Yes 33 (17.7) 153 (82.3) 1.41 (0.34–5.90) 0.634
Year(s) of treatment
 # 5 24 (14.1) 146 (85.9) 1.0
 . 5 11 (29.0) 27 (71.0) 1.95 (0.95–3.98) 0.067
Previous admission
  No 17 (11.4) 132 (88.6) 1.0
  Yes 18 (23.4) 59 (76.6) 1.94 (1.00–3.77) 0.051
Psychotic symptomsb
  No 27 (18.2) 121 (81.8) 1.00
  Yes 5 (7.8) 59 (92.2) 0.36 (0.14–0.94) 0.037
Mental disorders in family
  No 21 (13.4) 136 (86.6) 1.0
  First-degree relatives 6 (35.3) 11 (64.7) 2.39 (0.96–5.92) 0.060
  Other relatives 8 (19.0) 34 (81.0) 1.40 (0.62–3.17) 0.415
Suicide in family
  No 31 (15.1) 174 (84.9) 1.0
  Yes 4 (25.0) 12 (75.0) 2.03 (0.71–5.77) 0.184
Previous suicide attempts
  None 10 (12.2) 72 (87.8) 1.0
  One to two times 11 (12.0) 81 (88.0) 0.95 (0.40–2.24) 0.912
  More than two times 15 (28.3) 38 (71.7) 2.31 (1.04–5.19) 0.039
Previous suicidal ideation
  None 9 (13.0) 60 (87.0) 1.0
  One to two times 11 (11.6) 84 (88.4) 1.03 (0.43–2.49) 0.946
  More than two times 16 (26.2) 45 (73.8) 2.23 (0.98–5.06) 0.055
Lethality prior to admission
  No 21 (17.6) 98 (82.4) 1.0
  Yes 15 (13.9) 93 (86.1) 0.73 (0.38–1.43) 0.364
Smoking
  No 26 (15.4) 143 (84.6) 1.0
  Yes 10 (24.4) 31 (75.6) 1.53 (0.74–3.17) 0.255
Alcohol drinking
  No 22 (15.5) 120 (84.5) 1.0
  Yes 14 (20.6) 54 (79.4) 1.55 (0.79–3.03) 0.200
Any substance abuse
  No 33 (17.0) 161 (83.0) 1.0
  Yes 3 (18.8) 13 (81.2) 1.11 (0.34–3.62) 0.864
Medication adherence
  Highly 25 (15.9) 132 (84.1) 1.0
  Intermittent 8 (34.8) 15 (65.2) 1.82 (0.82–4.05) 0.138
  Poor 1 (5.0) 19 (95.0) 0.38 (0.050–2.78) 0.338
Antidepressant 
  No
 
2 (4.9)
 
39 (95.1)
 
1.0
 
(Continued)
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Table 4 Risk factors of suicide reattempts and adjusted hazard 
ratio (HR) (95% confidence interval [CI]) by multivariable Cox’s 
proportional-hazards regression analysis (n = 228)
Risk factors Adjusted HR (95% CI) P-value
Previous suicide attempts
  None 1.00
  One to two times 0.95 (0.40–2.27) 0.909
  More than two times 2.48 (1.07–5.76) 0.034
Antipsychotic
  No 1.00
  Typical 2.18 (0.82–5.79) 0.120
  Atypical 2.30 (0.53–9.95) 0.265
  Both 4.79 (1.39–16.52) 0.013
Antidepressant
  No 1.00
  Norepinephrine/serotonin 4.11 (0.55–30.60) 0.167
    Selective serotonin  
reuptake inhibitor
5.08 (1.14–22.75) 0.030
  Both 6.18 (1.13–33.65) 0.035
Table 3 (Continued)
Clinical factorsa Suicide reattempts Unadjusted HR 
(95% CI)
P-value
Yes (n = 36) No (n = 192)
  Norepinephrine/serotonin 2 (10.0) 18 (90.0) 2.40 (0.34–17.06) 0.381
  Serotonin alone 26 (18.3) 116 (81.7) 3.46 (0.82–14.60) 0.090
  Both 6 (24.0) 19 (76.0) 4.13 (0.83–20.49) 0.082
Antipsychotic
  No 5 (8.5) 54 (91.5) 1.0
  Typical 22 (17.5) 104 (82.5) 2.08 (0.79–5.51) 0.139
  Atypical 3 (17.6) 14 (82.4) 1.68 (0.40–7.05) 0.475
  Both 6 (23.1) 20 (76.9) 2.63 (0.80–8.66) 0.110
Anxiolytics
  No 10 (19.6) 41 (80.4) 1.0
  Benzodiazepine 22 (16.1) 115 (83.9) 1.09 (0.51–2.30) 0.829
  Others 2 (11.1) 16 (88.9) 0.78 (0.17–3.54) 0.744
  Both 2 (9.1) 20 (90.9) 0.57 (0.12–2.60) 0.468
Mood stabilizer
  No 25 (16.2) 129 (83.8) 1.0
  Lithium 6 (15.8) 32 (84.2) 0.84 (0.34–2.05) 0.705
  Others 5 (13.9) 31 (86.1) 0.80 (0.31–2.10) 0.659
Electroconvulsive therapy
  No 25 (15.1) 140 (84.9) 1.0
  Yes 11 (18.0) 50 (82.0) 1.06 (0.52–2.17) 0.861
Hospital stay (days) 
  Median (min–max)
 
14.5 (2–50)
 
13 (1–135)
 
1.00 (0.98–1.02)
 
0.992
Notes: aNumbers are n (%) or mean (± standard deviation); bat onset.
Abbreviation: ICD-10, International Statistical Classification of Diseases and Related Health Problems 10th Revision.
Stressful life events and psychotic symptoms were two 
risk factors associated with suicide reattempts found in the 
univariable analysis but not in the multivariable analysis. 
This is possibly because of the intercorrelation with one 
or more other variables. A previous study indicated that 
stressful life events play an important role in suicide 
attempts in patients with mood disorders,   particularly 
MDD patients.24 We found that having psychotic symp-
toms at the time of admission reduced the probability 
of suicide attempts, which is consistent with a previous 
study that suggested that psychosis may impair planning 
for suicide attempts.25
Currently, there are a few studies that determine risk 
factors of suicide reattempts in mood disorders. Most of the 
research reports risk factors associated with suicide attempts 
in MDD or BD separately. Therefore, inconsistencies 
between our findings and previous studies are partially due to 
the difference in population, methodology, assessment tools, 
statistical analysis, and small samples of some variables in 
this study. Other studies have found risk factors for suicide 
attempts that include male sex;7,8 increasing age (ie, 50 years 
or older);5,7 living alone on the day of the index attempt;9 
the method used in the index attempt;9,26 prior admission for 
suicide reattempt;8,9,19 family history of mental disorders;27 
previous suicidal ideation;25 somatic illness, such as cardio-
vascular disease and malignancies;7,28 abuse of psychophar-
macological agents, alcohol, or substances;28,29 bipolar,30,31 
depressed, and mixed episodes among BD patients; recurrent 
or refractory MDD, including those with psychosis;32 a posi-
tive family history of suicidal behaviors;27 not taking lithium; 
and short-term effects from electroconvulsive therapy.33
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There are some limitations of the present study. First, the 
generalizability of the study results may be limited to mood 
disorder patients visiting psychiatric hospitals. Those with 
severe physical injuries resulting from the attempted suicide 
were likely to be referred to a general hospital. Their charac-
teristics, such as lethality of the method used and severity of 
psychiatric illness, may be different. Second, data collected 
from medical folders were subject to incompleteness or 
missing variables, which caused a lack of power to identify 
associations. Third, the data relied exclusively on patient 
interview. Some information, such as drug and alcohol use, 
can be under-reported. Additionally, the effect of some 
variables, such as psychotic disease in family members or 
a family history of suicide, could be underestimated. These 
variables may be missed because patients were unaware of 
them, or they may remain unspoken due to stigma. Some 
factors were not assessed in this study by instruments used 
in other studies (eg, hopelessness and impulsiveness). Thus, 
their potential risk was not directly detected. Fourth, we 
used variables at the admission index date as risk factors. 
However, some factors can change over time and occur 
during follow-up, such as marital status, employment situa-
tion, development of depression, and medication adherence. 
These may have affected our findings. However, the aim of 
the study was to examine factors at one specific point in time 
that predict a high risk of repeated suicide attempts and thus 
possibly guide treatment. Finally, we found a final model that 
moderately explained the probability of suicide reattempts 
(73.3%). A larger sample size is required in future research 
to increase statistical power and should be prospectively used 
to confirm the study results.
In spite of some limitations, risk factors of suicide 
  reattempts in mood disorder patients were identified. For 
future research, risk factors for long-term suicide reattempts 
must be investigated, because they may differ somewhat 
from the short-term risk factors found in the present study. 
  Furthermore, risk factors categorized by subgroup of mood 
disorders (ie, MDD and BD) must be separately investigated 
to enable clinicians to provide intervention specifically 
directed for each subgroup. Finally, this study lacks statisti-
cal power to investigate risk factors for suicide completion 
and suicidal ideation. Future research on those issues is 
warranted.
Conclusion
Almost 40% of suicide reattempts in mood disorder patients 
in this study occurred within 90 days after their discharge 
from a psychiatric hospital. Factors placing patients at high 
risk for suicide reattempts were over two previous suicide 
attempts before the index admission, concomitantly being 
prescribed typical and atypical antipsychotics and antide-
pressants, and taking an SSRI alone or concomitantly with 
norepinephrine and/or serotonin reuptake inhibitors.
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